Clinical Updates in HER2+ mBC with ASCO coverage

 

University of Colorado Cancer Center
E

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Designing Targeted Drug Combinations

By University of Colorado Cancer Center FEATURING Elena Shagisultanova
By University of Colorado Cancer Center FEATURING Elena Shagisultanova
184 views
June 23, 2021
0 Comments
Login to view comments. Click here to Login
Clinical Updates in HER2+ mBC with ASCO coverage
05:41
Alicia Okines

2021 ASCO Updated Results of HER2CLIMB Study: Tucatinib vs. Placebo …

20:20
Penn Medicine Abramson Cancer Center

2021 Penn Medicine HER2+ MBC Updates

Feat. S. Bhattacharya
11:06
Total Health

Advances in HER2+ MBC: Management of CNS Metastases

Feat. T. Traina, L. Carey
09:00
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…

Feat. J. Abraham
17:39
Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Opt…

Feat. L. Schwartzberg
14:39
University of Kansas Cancer Center Post San Antonio Review

What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of …

Feat. H. McArthur
07:59
Azadeh Nasrazadani

Current Data on the Reduction in Risk of Developing New Brain Lesion…

06:50
Akshjot Puri

2021 ASCO Updates on Systemic Chemotherapy in Patients With Brain On…

07:27
Jennifer Plichta

2021 ASCO Highlights on the Survival Among Patients With Untreated M…

19:16
Sarah Sammons

2021 ASCO Update: Impact of Extracranial Disease Status on Survival …

07:12
Rachel Wuerstlein

ASCO 2021 Updates on the Safety of T-DM1 in Patients With HER2+ Loca…

10:50
University of Colorado Cancer Center

Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Comb…

Feat. E. Shagisultanova
05:23
Virtual Evolution: A Conference for Women by Women

Expert Panel Discussion on HER2+ MBC: What Are the RT Options for Br…

Feat. J. Crozier, M. Lima, R. L. Mahtani, K. Mirabeau-Beale, M. Rueda-Lara
18:14
University of Colorado Cancer Center

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Design…

Feat. E. Shagisultanova
24:44
Total Health

HER2+ BC Panel Discussion: Advances in Treatment and Sequencing of T…

Feat. L. Kennedy, B. Patterson, J. Petruney